Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 405166109 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Neuberger Berman Group LLC
13G/A
Amendment 1
|
11.1% |
10/6/2026
Event 9/30/2026
|
|
| Neuberger Berman Group LLC | 11.1% | ||
| Neuberger Berman Investment Advisers LLC | 10.8% | ||
| Neuberger Berman Genesis Fund | 6.1% | ||
| Markel Group Inc. 13D/A Amendment 6 | 42.0% |
9/14/2026
Event 9/11/2026
|
|
| Hagerty Holding Corp. 13D/A Amendment 3 | 56.5% |
9/11/2026
Event 9/9/2026
|
|
| Markel Group Inc. 13D/A Amendment 5 | 44.8% |
4/15/2026
Event 4/13/2026
|
|
| T. Rowe Price Investment Management, Inc. 13G | 5.7% |
11/14/2025
Event 9/30/2025
|
|
| State Farm Mutual Automobile Insurance Co 13D/A Amendment 6 | 53.5% |
11/6/2025
Event 11/4/2025
|
|
| Markel Group Inc. 13D/A Amendment 4 | 44.9% |
11/5/2025
Event 11/4/2025
|
|
|
Polar Capital Holdings Plc
13G/A
Amendment 2
|
5.9% |
9/4/2025
Event 6/30/2025
|
|
| Polar Capital Holdings Plc | 5.9% | ||
| Polar Capital LLP | 5.9% | ||
| Polar Capital Funds PLC - Biotechnology Fund | 5.9% | ||
| Hagerty Holding Corp. 13D/A Amendment 2 | 62.4% |
8/15/2025
Event 8/13/2025
|
|
|
Polar Capital Holdings Plc
13G/A
Amendment 1
|
0% |
8/14/2025
Event 6/30/2025
|
|
| Polar Capital Holdings Plc | 0% | ||
| Polar Capital LLP | 0% | ||
| Polar Capital Funds PLC - Biotechnology Fund | 0% | ||
| Hagerty Holding Corp. 13D/A Amendment 1 | 62.9% |
8/11/2025
Event 8/7/2025
|
|
| Markel Group Inc. 13D/A Amendment 3 | 47.7% |
4/18/2025
Event 4/16/2025
|
|
|
Neuberger Berman Group LLC
13G
|
5.3% |
2/4/2025
Event 12/31/2024
|
|
| Neuberger Berman Group LLC | 5.3% | ||
| Neuberger Berman Investment Advisers LLC | 5.3% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 4 | 1.45 M | $19.6 M |
| 2026 Q2 | 133 | 94.6 M | $1.17 B |
| 2026 Q1 | 120 | 90.7 M | $955 M |
| 2025 Q4 | 119 | 91.0 M | $1.22 B |
| 2025 Q3 | 102 | 89.7 M | $1.08 B |
| 2025 Q2 | 93 | 76.2 M | $770 M |
| 2025 Q1 | 93 | 75.8 M | $685 M |
| 2024 Q4 | 94 | 75.2 M | $726 M |
| 2024 Q3 | 83 | 73.9 M | $752 M |
| 2024 Q2 | 80 | 71.1 M | $740 M |
| 2024 Q1 | 82 | 70.0 M | $641 M |
| 2023 Q4 | 80 | 69.4 M | $542 M |
| 2023 Q3 | 78 | 70.7 M | $561 M |
| 2023 Q2 | 71 | 69.8 M | $644 M |
| 2023 Q1 | 65 | 66.4 M | $571 M |
| 2022 Q4 | 71 | 66.1 M | $555 M |
| 2022 Q3 | 61 | 67.1 M | $603 M |
| 2022 Q2 | 64 | 65.9 M | $758 M |
| 2022 Q1 | 53 | 63.6 M | $686 M |
| 2021 Q4 | 37 | 63.6 M | $896 M |